Epitogenesis, Inc.
EpitoGenesis, Inc. is a biotechnology company established in 2008, focused on designing and developing all-natural immune-enhancing adjuvants and delivery systems for prophylactic and therapeutic vaccines with an emphasis on safety. Their mission is to create efficacious vaccines that eliminate vaccination side effects and improve immune responses, leveraging patented technology based on synergy between dietary supplement molecules. The company has received multiple SBIR awards, has a team of field experts including Nobel laureates and university professors, and actively engages in research, collaborations, and publications to advance vaccine technology.
Industries
Nr. of Employees
small (1-50)
Epitogenesis, Inc.
Products
Immune-enhancing adjuvant nanoemulsion
A chemically defined formulation composed of select vitamins and naturally occurring polyphenols produced as an oil-in-water nanoemulsion for use as a vaccine adjuvant or dietary supplement to modulate immune responses.
Immune-enhancing adjuvant nanoemulsion
A chemically defined formulation composed of select vitamins and naturally occurring polyphenols produced as an oil-in-water nanoemulsion for use as a vaccine adjuvant or dietary supplement to modulate immune responses.
Services
Collaborative vaccine development projects
Partnership-based projects with research institutes to develop vaccine candidates using nutraceutical adjuvant formulations and mucosal delivery strategies.
Preclinical immunogenicity testing and evaluation
Preclinical testing services in murine models to assess antigen-specific immune responses following mucosal and systemic vaccination with candidate formulations.
Advisory and strategy for mucosal vaccination
Consultation on mucosal vaccination strategies, route selection, and adjuvant safety profiling based on published reviews and internal research.
Collaborative vaccine development projects
Partnership-based projects with research institutes to develop vaccine candidates using nutraceutical adjuvant formulations and mucosal delivery strategies.
Preclinical immunogenicity testing and evaluation
Preclinical testing services in murine models to assess antigen-specific immune responses following mucosal and systemic vaccination with candidate formulations.
Advisory and strategy for mucosal vaccination
Consultation on mucosal vaccination strategies, route selection, and adjuvant safety profiling based on published reviews and internal research.
Expertise Areas
- Vaccine adjuvant development
- Mucosal immunology and mucosal vaccine delivery
- Nanoemulsion formulation
- Preclinical immunogenicity testing (murine models)
Key Technologies
- Oil-in-water nanoemulsion formulation
- Nutraceutical-based adjuvant formulations (vitamins and polyphenols)
- Mucosal vaccine delivery routes (oral, vaginal, rectal)
- Preclinical murine immunogenicity models